Breaking News

Dipharma Completes Second Phase of CGMP Expansion at Kalamazoo Site

Continues to expand capabilities in the North American market providing additional CGMP, Quality Control laboratory and warehouse spaces.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Dipharma Francis S.r.l., a global CDMO and manufacturer of Active Pharmaceutical Ingredients and advanced Intermediates, has completed the second phase of expansion of its American site, Dipharma Inc. in Kalamazoo, MI.   The new investment provides additional CGMP, Quality Control laboratory and warehouse spaces, increasing capabilities to support and expand its CDMO services at the site. The state-of-the-art QC lab is designed and equipped according to the latest pharmaceutical quality standa...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters